A different kind of fasting is the Fasting Mimicking Diet, or FMD, as the experts at Ackerman Cancer Center said. One in eight women in America will develop breast cancer in their lifetime, the numbers from the American Cancer Society show. And just last month, Nature Communications published research from a randomized phase 2 trial that analyzed the impact of FMD in breast cancer patients under chemotherapy. Researchers found that FMD can sensitize breast cancer cells to chemotherapy both at the clinical and pathological levels. “Instead, fasting deprives proliferating cancer cells of nutrients, growth and other factors, which renders them more sensitive to cancer therapy and increases cell death."